Filing Flows › Comparisons › NAGE vs FTLF
Niagen Bioscience vs Fitlife Brands: NAGE and FTLF compared
Niagen Bioscience is the larger company: $27.2M of revenue in its latest quarter (Q3 2026) against $26.5M for Fitlife Brands (Q2 2026). Fitlife Brands is growing faster (+65% against -20% a year earlier). Fitlife Brands is more profitable, with an operating margin of 12.6% against -5.8%.
Where the money goes: NAGE and FTLF
Niagen Bioscience (NAGE) · Q3 2026
Niagen Bioscience, Q3 2026: revenue $27.2M (-20% year over year), operating margin -5.8%, net loss $1.2M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.
Fitlife Brands (FTLF) · Q2 2026
Fitlife Brands, Q2 2026: revenue $26.5M (+65% year over year), operating margin 12.6%, net earnings $1.9M, operating cash flow $3.6M. The chart follows the revenue to costs, profit and cash.
| Niagen Bioscience (NAGE) | Fitlife Brands (FTLF) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $27.2M | $26.5M |
| Revenue growth, Y/Y | -20% | +65% |
| Gross margin | — | 37.0% |
| Operating margin | -5.8% | 12.6% |
| Net earnings | −$1.2M | $1.9M |
| Net margin | -4.3% | 7.3% |
| Operating cash flow | $2.6M | $3.6M |
Where the revenue comes from
Niagen Bioscience
- Consumer Products segment: $23.3M (86%)
- Ingredients segment: $3.8M (14%)
Fitlife Brands
- Irwin: $14.1M (53%)
- Legacy FitLife: $12.4M (47%)
Questions
Which is bigger, Niagen Bioscience or Fitlife Brands?
Niagen Bioscience is the larger company: $27.2M of revenue in its latest quarter (Q3 2026) against $26.5M for Fitlife Brands (Q2 2026).
Is Niagen Bioscience or Fitlife Brands growing faster?
Fitlife Brands is growing faster (+65% against -20% a year earlier).
Which is more profitable, Niagen Bioscience or Fitlife Brands?
Fitlife Brands is more profitable, with an operating margin of 12.6% against -5.8%.
More: Niagen Bioscience earnings · how Niagen Bioscience makes money · Fitlife Brands earnings · how Fitlife Brands makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.